SEC Form 4 · accession 0001179110-16-022848
CymaBay Therapeutics, Inc. · CBAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sujal Shah
Officer — Chief Financial Officer
Period of report
Apr 4, 2016
Accepted (ET)
Apr 6, 2016 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042074
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 4, 2016 | P | 22,000 | $1.39 | A | 42,000 | D | |
| Common Stock | Apr 5, 2016 | P | 33,000 | $1.39 | A | 75,000 | D |
Table II — derivative securities
No Table II lines on this filing.